OptimizeRx Corp. is digital health company, engaged in the provision of digital health messaging via electronic health records, which serve as a direct channel for pharmaceutical companies to communicate with healthcare providers. The company is headquartered in Waltham, Massachusetts and currently employs 106 full-time employees. The company went IPO on 2005-05-18. The company offers diverse tech-enabled marketing solutions through its artificial intelligence (AI)-generated Dynamic Audience and Activation Platform (DAAP), which enables customers to execute traditional marketing campaigns on its digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. Its principal solutions include Audience Development, Audience Activation and Media Execution and Financial Messaging. Its Financial Messaging solutions provide prescribers visibility to branded copay offers directly within their electronic health record (EHR) systems and/or electronic prescribing (ERx) platforms.
Mr. Stephen Silvestro is the President of OptimizeRx Corp, joining the firm since 2019.
What is the price performance of OPRX stock?
The current price of OPRX is $7.15, it has decreased 0.34% in the last trading day.
What are the primary business themes or industries for OptimizeRx Corp?
OptimizeRx Corp belongs to Health Care industry and the sector is Health Care
What is OptimizeRx Corp market cap?
OptimizeRx Corp's current market cap is $133.3M
Is OptimizeRx Corp a buy, sell, or hold?
According to wall street analysts, 8 analysts have made analyst ratings for OptimizeRx Corp, including 4 strong buy, 7 buy, 2 hold, 0 sell, and 4 strong sell